BASIC AND CLINICAL IMMUNOLOGY SECOND EDITION Commissioning Editor: Timothy Horne Development Editor: Ailsa Laing Project Manager: Emma Riley Designer: Sarah Russell/Kirsteen Wright Illustration Manager: Kirsteen Wright/Gillian Richards BASIC AND CLINICAL IMMUNOLOGY SECOND EDITION Mark Peakman MBBS PhD FRCPath Professor of Clinical Immunology, King’s College London; Honorary Consultant Immunologist, King’s College Hospital, London Diego Vergani MD PhD FRCPath FRCP Professor of Liver Immunopathology, King’s College London; Honorary Consultant Immunologist, King’s College Hospital, London Illustrated by Danny J. Pyne Martin Woodward and EDINBURGH LONDON NEW YORK OXFORD PHILADELPHIA ST LOUIS SYDNEY TORONTO 2009 First Edition © 1997, Elsevier Limited. Second Edition © 2009, Elsevier Limited. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any information storage and retrieval system, without permission in writing from the publisher. Permissions may be sought directly from Elsevier’s Rights Department: phone: (+1) 215 239 3804 (USA) or (+44) 1865 843830 (UK); fax: (+44) 1865 853333; e-mail: [email protected]. You may also complete your request on-line via the Elsevier website at http://www.elsevier.com/permissions. ISBN: 978 0 443 10082 6 British Library Cataloguing in Publication Data A catalogue record for this book is available from the British Library Library of Congress Cataloging in Publication Data A catalog record for this book is available from the Library of Congress Notice Knowledge and best practice in this fifield are constantly changing. As new research and experience broaden our knowledge, changes in practice, treatment and drug therapy may become necessary or appropriate. Readers are advised to check the most current information provided (i) on procedures featured or (ii) by the manufacturer of each product to be administered, to verify the recommended dose or formula, the method and duration of administration, and contraindications. It is the responsibility of the practitioner, relying on their own experience and knowledge of the patient, to make diagnoses, to determine dosages and the best treatment for each individual patient, and to take all appropriate safety precautions. To the fullest extent of the law, neither the Publisher nor the Authors assume any liability for any injury and/or damage to persons or property arising out or related to any use of the material contained in this book. The Publisher Working together to grow libraries in developing countries www.elsevier.com | www.bookaid.org | www.sabre.org The publisher’s policy is to use paper manufactured from sustainable forests Printed in China Preface to the second edition Since the publication of the fifirst edition of Basic and Clinical array of receptors for pathogens, the discovery of which has Immunology, there have been two main forces driving us changed the way we think about interactions between the inexorably towards this new edition. ThThe fifirst has been the immune system and the environment. We speculated in the continuous, and very much appreciated, commentary from fifirst edition about the potential for ‘magic bullet’ monoclonal our students and peers that Basic and Clinicall was an impres- antibody therapy, but could not have dreamt of the benefifit sive fifirst effffff ort. It clearly fifilled a gap, as we had intended, now being realised in a number of mainstream clinical set- between the basic and theoretical immunology found in tings, that include rheumatoid arthritis, lymphoma and many textbooks, and the advanced clinical immunology breast cancer. ThTh e tools have evolved too — technology for found in others. By combining the main elements of both, the investigation and imaging of the immune system now we had created a single text that was usable in biomedical, allows single immune cells to be tracked in vivo. And, inevi- medical and health schools. ThTh e second driver was the emer- tably, there is a new T helper cell on the block, along with gence of landmark discoveries in the understanding of the reincarnation of the suppressor T cell (only it is called a immunity and its application to medicine, which began to regulator). One has the sense that much has happened and date our fifi rst book all too quickly. much will happen hence. In 1997 we had devoted just a few lines to dendritic cells; they are now viewed as the master controllers of adaptive London M.P. immunity. ThThis potency is achieved through expression of an 2009 D.V. v Preface to the fifirst edition ‘Immunology is an invention of the devil.’ dence that immunology was truly demonic, a conversation with an expert physician, encountered at an international From the outset, this book was intended as a text combining conference, was recounted in the same article. ‘I hope you the basic science components required to understand the understand all this stuff ’, he had said to the journalist, ‘they role of immunity in disease with an account of the major didn’t teach it when I was in medical school and I never diseases classififi ed under the umbrella of clinical immunol- fifi gured it out.’ We hope that this book goes some way towards ogy. ThThe book would thus naturally span the curricula of redressing the balance. most medical or paramedical courses, from basic to applied. It would have been impossible to be authoritative about From technical, medical, dental and science students at all every aspect of clinical immunology. For this reason, we have levels, we had both perceived a glaring need for such a text. consulted friends and colleagues with the relevant expertise But as if any stimulus was required for us to see the project to advise us, and to these we are indebted: Fred Dische, to completion, an article appeared in a popular news maga- Adrian Eddleston, John Fabre, Jonathan Frankel, Elizabeth zine for doctors whilst the book was being planned, asking Higgins, Rob Higgins, William Hirst, Giorgina Mieli-Vergani, several regular contributors for their most hated words. Lindsay Nicholson and Anton Pozniak. We are also grateful ‘Immunology’ made its appearance as ‘an invention of the to colleagues who provided photographic material for illus- devil, who is making it up as he goes along because he is trations, notably Nat Cary, Fred Dische and Magnus Norman, not too clear about this stuffff either’. ThTh e article went on Jane Evanson, Stella Knight, Jonathan Frankel, Elizabeth to compare immunology to a Rube Goldberg or Heath Higgins, Patrick O’Donnell, Bernard Portmann and John Robinson cartoon: for example, the light is turned on when Salisbury. you trip over a chair, startling the cat, who leaps against the door, which swings shut, knocking a picture offff the wall, London M.P. which strikes the light switch as it falls. And as a fifinal evi- 1997 D.V. vi Contents 1 Anatomyy and cells of the immune syystem 1 2 Innate immunityy I: pphyysical and humoral pprotection 11 3 Innate immunityy II: cellular mechanisms 23 4 Acqquired immunityy: antiggen recepptors 35 5 The human leukocyyte antiggens 55 6 Cellular immune respponses I: dendritic cells, macropphagges and B lyympphocyytes 71 Cellular immune responses II: T lymphocytes, antigen presentation and natural 7 killer cells 87 8 The immune response to microbes: an overview 115 9 Tolerance and mechanisms of autoimmunity 121 10 Hypersensitivity reactions and clinical allergy 133 11 Transplantation 151 12 Rheumatic diseases 167 13 Endocrine autoimmune disease 189 14 Liver diseases 203 15 Gastrointestinal diseases 211 16 Immune-mediated nephritis and vasculitis 219 17 Immune-mediated skin disease 239 18 Immune-mediated diseases of the nervous system and eye 249 19 Immunodefifi ciency 265 20 Human immunodefifi ciency virus and AIDS 283 21 Immunological manifestations of haematological disease 293 22 Immune-based therapies 307 23 Immunisation 323 Appendices 1: Commonly encountered CD molecules 334 2: Major cytokines, cells releasing them, targets and functions 342 3: List of class II human leukocyte antigen alleles 346 4: Abbreviations used for amino acids 347 Index 349 vii Symbols used in the diagrams LFA-1 ICAM-1 P-selectin E-selectin L-selectin CD8 TCR CD4 molecule molecule Lymphocyte AAAAAAAAAPPPPPPCCCCCC L Antigen presenting cell Dendritic cell B-lymphocyte NK cell B NK T-lymphocyte Plasma cell T Class I MHC molecule (blue) with associated peptide (orange) Macrophage Neutrophil P and TCR (green) CD8 CD4 Mast cell Basophil CTL TH1 TH2 Treg Eosinophil Class II MHC molecule (red) with associated peptide (orange) and TCR (green) Stimulates/enhances Inhibits/kills Becomes viii 1 Anatomy and cells of the immune system the blood. ThTh e granulocytes constitute approximately 65% of Cells of the immune system 1 all white cells and derive their name from the large numbers Granulocytes 1 of granules found in their cytoplasm. ThThe appearance of Monocytes and dendritic cells 1 these granules under the light microscope following conven- Lymphocytes 2 tional staining provides a further subdivision. Granules with Natural killer cells 3 intense blue staining are found in basophils, which make up 0.5–1% of granulocytes; red-staining granules are present in Organs of the immune system 5 eosinophils (3–5%); while neutrophils (90–95%) have gran- Primary lymphoid organs 5 ules that remain relatively unstained (Fig. 1.2a–c). ThThe term ‘polymorphonuclear cell’, describing the multilobed nuclei Secondary lymphoid organs 6 of granulocytes, has become synonymous with neutrophils, which constitute by far the majority of granulocytes, but eosinophil nuclei may have a similar appearance. Granulo- ThTh e immune system is like any other organ of mammalian cytes circulate in the blood and migrate into the tissues par- physiology — the liver, kidney, thyroid — in being composed ticularly during inflfl ammatory responses. ThThe exception to of specialised cells that function within discrete, organised this rule is the mast cell, which is fifixed in the tissues. Mast anatomical structures. To understand its role in host defence, cells and basophils share many common features, yet their it is necessary fifirst to become familiar with the cells and derivation is difffffferent: the basophil is of the same lineage as anatomy of the immune system. neutrophils and eosinophils, whilst mast cells arise from an as yet unidentifified precursor possibly in the spleen, thymus or lymph node. Cells of the immune system ThTh e bone marrow is the source of the precursor cells that Monocytes and dendritic cells ultimately give rise to the cellular constituents of the immune system, save for one brief period during foetal life when the Monocytes form between 5 and 10% of circulating white liver is also a site of immune cell development. ThThe produc- blood cells and have a short half-life, spending approximately tion of immune cells is one component of haemopoiesis, the 24 hours in the blood. ThThey enter the extravascular pool and process by which all cells that circulate in the blood arise and become resident in the tissues, where they are termed mac- mature. An important underlying principle of haemopoiesis rophages. Whilst each macrophage was thought to derive is that there is a single precursor cell that is capable of giving from a single monocyte, there is now evidence that macro- rise to all blood cell lineages, ranging from platelets to lym- phages may also arise following division of immature forms phocytes (Fig. 1.1). ThThis cell is known as the pluripotent of monocytes. Monocyte and macrophage morphology is haemopoietic stem cell: it is to the bone marrow what the highly variable, but in broad terms they are larger than neu- queen bee is to the hive (Science Box 1.1). Immunology trophils and lymphocytes, have a single nucleus and abun- concentrates upon the roles of white blood cells in host dant granular cytoplasm (Fig. 1.2d). Several specialised forms defence: these include the granulocytes (neutrophils, eosino- of the mature cell exist, including alveolar macrophagesin phils and basophils), monocytes and dendritic cells, and the lung, Kupffffffer cells in the liver, mesangial cells in the lymphocytes. kidney, microglial cellsin the brain, osteoclastsin bone, and other macrophages lining channels in the spleen and lymph Granulocytes nodes. ThTh ere is an additional very small population of immune ThTh e granulocyte/monocyte lineage gives rise to precursors cells in the peripheral blood, lymph nodes, bone marrow and that mature within the bone marrow and are released into tissues that have a characteristic appearance of numerous 1